Eikonoklastes is advancing a new generation of tissue factor (TF) immunotherapies – therapeutics designed to target the cell surface receptor now known to be prevalent on key components of the tumor microenvironment.

Biotechnology

Education

Eikonoklastes Therapeutics

Eikonoklastes Therapeutics' headquarters in Cincinnati, OH, United States

Bruce Halpryn

Vishal Agrawal

Samuel Lee, MD, MBA

Samuel Lee

Tom Finn

Kenneth Morand

Neel Patel

Meyer Frucher

Seward Rutkove

Michael O’Beirne

Mark Tuszynski

Dame Pamela Shaw

Russell Lonser

Description

People (2)

Bruce Halpryn

Tom Finn

Jobs